Form 4: Cencora CEO Exercises Options, Sells Shares
Insider Transaction Report
Cencora's President and CEO, Robert P. Mauch, exercised stock options and subsequently sold a portion of his common stock holdings under a pre-arranged trading plan.
Summary
- Robert P. Mauch, President & CEO and Director of Cencora, Inc. (COR), reported transactions on September 18, 2025.
- Mauch exercised non-qualified stock options to acquire 3,763 shares of common stock at an exercise price of $86.09 per share.
- Concurrently, Mauch sold 5,097 shares of common stock at a price of $290.00 per share.
- The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on November 15, 2024.
- Following these transactions, Mauch beneficially owns 39,274 shares of Cencora common stock directly.
- He also holds 18,814 non-qualified stock options.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions (option exercise and sale under a 10b5-1 plan), which are common for executives managing their compensation and personal finances. While a net sale occurred, the pre-planned nature mitigates immediate negative sentiment.
Positives
- The exercise of stock options indicates the executive is realizing value from their compensation, suggesting confidence in the stock's past performance up to the exercise date.
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which suggests a planned liquidity event rather than an immediate reaction to new, undisclosed negative information.
Negatives
- The disposition of 5,097 shares by a key executive (President & CEO) could be perceived negatively by the market, as it reduces their direct ownership stake.
- The number of shares sold (5,097) is greater than the number of shares acquired through option exercise (3,763), resulting in a net reduction of 1,334 shares in direct beneficial ownership from the transactions reported.
Future Outlook
na
Industry Context
na
Stakeholder Impact
- Shareholders: May view the net sale by the CEO as a slight negative, though the 10b5-1 plan provides context. It could lead to minor short-term price fluctuations.
Key Dates
| Date | Description |
|---|---|
| 11/13/2020 | First installment exercisable date for non-qualified stock option |
| 11/13/2021 | Second installment exercisable date for non-qualified stock option |
| 11/13/2022 | Third installment exercisable date for non-qualified stock option |
| 11/13/2023 | Fourth installment exercisable date for non-qualified stock option |
| 11/15/2024 | Date Rule 10b5-1 trading plan was adopted |
| 09/18/2025 | Date of stock option exercise and common stock sale |
| 09/22/2025 | Signature date of the Form 4 filing |
| 11/13/2026 | Expiration date of non-qualified stock option |
Recommendation
holdThe filing details a pre-planned insider transaction involving both option exercise and a subsequent sale of shares. While the net effect is a reduction in the CEO's direct beneficial ownership, the execution under a Rule 10b5-1 plan suggests a systematic approach to liquidity rather than a reaction to new, adverse company-specific news. This type of transaction is common for executives managing their personal finances and compensation. Without additional company-specific news or broader market context, this single Form 4 filing does not provide sufficient grounds for a strong buy or sell recommendation, thus a 'hold' is appropriate.
Keywords
Cencora, COR, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Robert P. Mauch, CEO, Director, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.